The progression and high mortality of chronic arterial diseases - like atherosclerosis and aneurysms - are intimately associated with the activity of pro-inflammatory pathways1,2, of which the NF-κB pathway has been extensively studied3–5. Here, NFKB1 is linked to atherosclerosis.